HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natalie Ives Selected Research

Hallucinations (Hallucination)

7/2010Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Natalie Ives Research Topics

Disease

20Parkinson Disease (Parkinson's Disease)
01/2022 - 10/2009
5Melanoma (Melanoma, Malignant)
01/2018 - 09/2002
3Chronic Renal Insufficiency
10/2021 - 02/2016
3Stroke (Strokes)
01/2018 - 06/2014
2Shock
04/2022 - 01/2022
2Respiratory Tract Infections (Respiratory Tract Infection)
03/2022 - 01/2022
2Nephrotic Syndrome (Syndrome, Nephrotic)
03/2022 - 01/2022
2Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
01/2020 - 09/2017
2Renal Artery Obstruction (Renal Artery Stenosis)
01/2019 - 11/2009
2Hypoxia (Hypoxemia)
01/2018 - 01/2017
2Infections
03/2013 - 11/2011
2Disease Progression
11/2011 - 10/2009
2Dyskinesias (Dyskinesia)
03/2011 - 07/2010
1Cerebral Infarction
04/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2022
1Wounds and Injuries (Trauma)
04/2022
1Virus Diseases (Viral Diseases)
01/2022
1Hyperkalemia
10/2021
1Mental Disorders (Mental Disorder)
02/2021
1Weight Loss (Weight Reduction)
01/2021
1Hemorrhage
01/2020
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2020
1Vascular Diseases (Vascular Disease)
01/2019
1Neoplasms (Cancer)
01/2018
1Migraine Disorders (Migraine)
01/2018
1Headache (Headaches)
01/2018
1Critical Illness (Critically Ill)
01/2017
1Dementia (Dementias)
09/2014
1Vasculitis (Vasculitides)
03/2013
1Helicobacter Infections
11/2011
1Hallucinations (Hallucination)
07/2010
1Sleep Initiation and Maintenance Disorders (Insomnia)
07/2010
1Sleepiness
07/2010
1Hypotension (Low Blood Pressure)
07/2010
1Vomiting
07/2010
1Constipation
07/2010
1Dizziness (Lightheadedness)
07/2010
1Nausea
07/2010
1Chorea (Rheumatic Chorea)
11/2009
1Huntington Disease (Huntington's Disease)
11/2009

Drug/Important Bio-Agent (IBA)

7Levodopa (L Dopa)FDA LinkGeneric
01/2022 - 07/2010
5Monoamine Oxidase (MAO)IBA
01/2022 - 10/2009
4Dopamine Agonists (Dopamine Agonist)IBA
01/2022 - 07/2010
4InterferonsIBA
01/2018 - 09/2002
4Pharmaceutical PreparationsIBA
09/2017 - 06/2010
3Oxygen (Dioxygen)IBA
01/2018 - 06/2014
2Prednisolone (Predate)FDA LinkGeneric
03/2022 - 01/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2022 - 01/2022
2Spironolactone (Aldactone)FDA LinkGeneric
10/2021 - 09/2017
2Chlorthalidone (Chlortalidone)FDA LinkGeneric
10/2021 - 09/2017
2GlucocorticoidsIBA
01/2020 - 03/2013
22- (1- (5- (cyclohexylcarbamoyl)- 6- propylsulfanylpyridin- 2- yl)- 3- piperidyl)acetic acidIBA
01/2020 - 09/2017
2Oxidoreductases (Dehydrogenase)IBA
01/2020 - 09/2017
1Sodium ChlorideFDA LinkGeneric
04/2022
1Prednisone (Sone)FDA LinkGeneric
01/2022
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2022
1AmberIBA
01/2021
1EnzymesIBA
01/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2020
1Type A Botulinum Toxins (Botox)FDA Link
01/2018
1Botulinum Toxins (Botulinum Toxin)IBA
01/2018
1IpilimumabIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1antineoplaston A10 (A 10)IBA
01/2018
1Antiviral Agents (Antivirals)IBA
01/2017
1ValganciclovirFDA Link
01/2017
1Valacyclovir (Valtrex)FDA LinkGeneric
01/2017
1Proteins (Proteins, Gene)FDA Link
02/2016
1propylene diquat (PDQ(+))IBA
01/2016
1Antihypertensive Agents (Antihypertensives)IBA
11/2011
1Anti-Bacterial Agents (Antibiotics)IBA
11/2011
1Isradipine (Dynacirc)FDA LinkGeneric
11/2011
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
11/2011
1TEMPOIBA
06/2011
1nabilone (Cesamet)FDA Link
11/2009
1Dopamine Agents (Dopaminergic Agents)IBA
10/2009
1Interferon-alpha (Interferon Alfa)IBA
08/2003

Therapy/Procedure

20Therapeutics
01/2022 - 08/2003
3Language Therapy (Language Training)
08/2021 - 06/2014
2Plasma Exchange
01/2020 - 03/2013
2Contraindications
01/2018 - 01/2017
2Occupational Therapy (Therapy, Occupational)
03/2016 - 01/2016
1Time-to-Treatment
04/2022
1Resuscitation
04/2022
1Blood Transfusion (Blood Transfusions)
01/2022
1Continuity of Patient Care
02/2021
1Injections
01/2018
1Activities of Daily Living (ADL)
01/2016
1Physical Therapy Modalities (Physical Therapy Technique)
08/2012
1Deep Brain Stimulation
06/2010